- You can view the full 3M Ratings Report.
- Use our conglomerates section to find sector-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.
M&A may dominate headlines, but investors need to watch earnings as well, says Jim Cramer.
India drugmaker Intas will pay about $770 million for the UK and Ireland generics assets.